Serina Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Serina Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2017 to Q4 2023.
  • Serina Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $20.8M, a 12.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $20.8M +$2.36M +12.8% Dec 31, 2023 10-K 2024-03-22
Q4 2022 $18.5M +$244K +1.34% Dec 31, 2022 10-K 2024-03-22
Q4 2021 $18.2M +$389K +2.18% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $17.8M +$2.12M +13.5% Dec 31, 2020 10-K 2022-03-29
Q4 2019 $15.7M +$3.47M +28.3% Dec 31, 2019 10-K 2021-03-31
Q4 2018 $12.2M +$2.2M +21.9% Dec 31, 2018 10-K/A 2020-03-31
Q4 2017 $10M Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.